Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elgene Lim

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Cancer Immunology Research|August 30, 2017
Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBCNatasha K Brockwell, Katie L Owen, Damien Zanker, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
<sup>64</sup>Cu-SAR-Bombesin PET-CT Imaging in the Staging of Estrogen/Progesterone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients: Safety, Dosimetry and Feasibility in a Phase I TrialKeith Wong, Gemma Sheehan-Dare, Andrew Nguyen, et al.
Journal of Medical Imaging and Radiation Oncology|October 22, 2021
Diagnostic value of <sup>68</sup> Ga-DOTATATE PET-CT imaging for staging of ER<sup>+</sup> /PR<sup>+</sup> HER2- breast cancer patients with metastatic disease: Comparison with conventional imaging with bone scan, diagnostic CT and <sup>18</sup> F-FDG PET-CT in a prospective pilot trialAndrew Nguyen, Karen Fullard, Gemma Sheehan-Dare, et al.
ANZ Journal of Surgery|November 27, 2019
Window of opportunity treatment in breast cancerJulia Chen, Neshanth Easwaralingam, Sanjay Warrier, et al.
Cancer Cell|June 15, 2013
PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cellsGilles Buchwalter, Michele M Hickey, Anne Cromer, et al.
Genome Biology|February 5, 2024
The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancerLeila Hosseinzadeh, Zoya Kikhtyak, Geraldine Laven-Law, et al.
Growth Factors (Chur, Switzerland)|February 1, 2024
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosisEmma J Thompson, Samantha Escarbe, Denis Tvorogov, et al.
Endocrine-Related Cancer|December 18, 2018
Non-canonical AR activity facilitates endocrine resistance in breast cancerKeeMing Chia, Heloisa Milioli, Neil Portman, et al.
Cancer Discovery|September 26, 2014
PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repairYiduo Hu, Sarah A Petit, Scott B Ficarro, et al.
BMC Genomics|March 6, 2024
Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profilingTimothy J Peters, Braydon Meyer, Lauren Ryan, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Cancer Immunology Research|August 30, 2017
Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBCNatasha K Brockwell, Katie L Owen, Damien Zanker, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
<sup>64</sup>Cu-SAR-Bombesin PET-CT Imaging in the Staging of Estrogen/Progesterone Receptor Positive, HER2 Negative Metastatic Breast Cancer Patients: Safety, Dosimetry and Feasibility in a Phase I TrialKeith Wong, Gemma Sheehan-Dare, Andrew Nguyen, et al.
Journal of Medical Imaging and Radiation Oncology|October 22, 2021
Diagnostic value of <sup>68</sup> Ga-DOTATATE PET-CT imaging for staging of ER<sup>+</sup> /PR<sup>+</sup> HER2- breast cancer patients with metastatic disease: Comparison with conventional imaging with bone scan, diagnostic CT and <sup>18</sup> F-FDG PET-CT in a prospective pilot trialAndrew Nguyen, Karen Fullard, Gemma Sheehan-Dare, et al.
ANZ Journal of Surgery|November 27, 2019
Window of opportunity treatment in breast cancerJulia Chen, Neshanth Easwaralingam, Sanjay Warrier, et al.
Cancer Cell|June 15, 2013
PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cellsGilles Buchwalter, Michele M Hickey, Anne Cromer, et al.
Genome Biology|February 5, 2024
The androgen receptor interacts with GATA3 to transcriptionally regulate a luminal epithelial cell phenotype in breast cancerLeila Hosseinzadeh, Zoya Kikhtyak, Geraldine Laven-Law, et al.
Growth Factors (Chur, Switzerland)|February 1, 2024
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosisEmma J Thompson, Samantha Escarbe, Denis Tvorogov, et al.
Endocrine-Related Cancer|December 18, 2018
Non-canonical AR activity facilitates endocrine resistance in breast cancerKeeMing Chia, Heloisa Milioli, Neil Portman, et al.
Cancer Discovery|September 26, 2014
PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repairYiduo Hu, Sarah A Petit, Scott B Ficarro, et al.
BMC Genomics|March 6, 2024
Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profilingTimothy J Peters, Braydon Meyer, Lauren Ryan, et al.
Pageof 13